BCG vaccination and tuberculosis in Japan

Journal of Epidemiology

Volumn 13, Issue 3, 2003, Pages 127-135

  Rahman, Mahbubur ^a,b   Takahashi, Osamu ^a   Goto, Masashi ^a   Fukui, Tsuguya ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Japan)

Author keywords

BCG; Cost effectiveness; Japan; Tuberculosis

Indexed keywords

BCG VACCINE;

ADOLESCENT; ADULT; CHILD; COST BENEFIT ANALYSIS; DEVELOPED COUNTRY; DRUG SURVEILLANCE PROGRAM; ECONOMICS; EPIDEMIC; HUMAN; INCIDENCE; INFANT; INJECTION; JAPAN; MASS IMMUNIZATION; METHODOLOGY; NEWBORN; PRESCHOOL CHILD; REVIEW; STATISTICS; TREATMENT OUTCOME; TUBERCULOSIS;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; BCG VACCINE; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DEVELOPED COUNTRIES; DISEASE OUTBREAKS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INJECTIONS; JAPAN; MASS IMMUNIZATION; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 0038348808     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.13.127     Document Type: Review

References (46)

1. Aoki M. Characteristics of tuberculosis in Japan compared with those in other developed countries. Kekkaku 1993 ;68:533-8. (in Japanese)
2. Statistics of TB during 1996 in Japan. Ministry of Health and Welfare, Japan, 1997. (in Japanese)
3. Statistics of TB during 2000 in Japan. Ministry of Health and Welfare, Japan, 2001. (in Japanese)
4. Tuberculosis Prevention Trial, Madras. Trial of BCG vaccines in south India for tuberculosis prevention. Indian J Med Res 1980;72(Suppl):1-74.
5. BCG: bad news from India. Lancet 1980;1:73-4.
6. BCG vaccination after the Madras study. Lancet 1981;1:309-10.
7. Fine PEM. BCG vaccination against tuberculosis and leprosy. Br Med Bull 1988;44:691-703.
8. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature JAMA 1994;271:698-702.
9. Rahman M, Sekimoto M, Takamatsu I, Hira K, Shimbo T, Toyoshima K, et al. Economic evaluation of universal BCG vaccination in Japanese infants. Int J Epidemiol 2001;30:380-5.
10. Criteria for discontinuation of vaccination programmes using Bacille Calmette-Guerin (BCG) in countries with a low prevalence of tuberculosis. A statement of the International Union Against Tuberculosis and Lung Disease. Tuber Lung Dis 1994;75:179-80.
11. Aoki M. Tuberculosis control strategy in the 21st century in Japan - for elimination of tuberculosis in Japan. Kekkaku 2001;76:549-57. (in Japanese)
12. Tripathy SP. Fifteen-year follow-up of the Indian BCG prevention trial. In: International Union against Tuberculosis, ed. Proceedings of the XXVIth IUAT World Conference on Tuberculosis and Respiratory Diseases. Singapore: Professional Postgraduate Services International, 1987:69-72.
13. Fine PEM. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995;346:1339-45.
14. Takamatsu I, Kameda M, Inoue T, Toyoshima K. Assessment of effectiveness of BCG vaccination against childhood tuberculosis. Kekkaku 1995;70:561-6.
15. Smith PG. Epidemiological methods to evaluate vaccine efficacy. Br Med Bull 1988;44:679-90.
16. Lugosi L. Theoretical and methodological aspects of BCG vaccine from the discovery of Calmette and Guerin to molecular biology. A review. Tuber Lung Dis 1992;73:252-61.
17. Kubit S, Czajka, Olakowski T, Piasecki Z. Effectiveness of BCG vaccination. Pediatr Pol 1983;58:775-81.
18. Sepulveda RL, Parcha C, Sorensen RU. Case-control study of the efficacy of BCG immunization against pulmonary tuberculosis in young adults in Santiago, Chile. Tuber Lung Dis 1992;73:372-7.
19. Randomized controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group. Lancet 1996;348:17-24.
20. Tala-Heikkila MM, Tuominen JE, Tala EO. Bacillus Calmette-Guerin revaccination questionable with low tuberculosis incidence. Am J Respir Crit Care Med 1998;157:1324-7.
21. Leung CC, Tam CM, Chan SL, Chan-Yeung M, Chan CK, Chang KC. Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong. Int J Tuberc Lung Dis 2001;5:717-23.
22. Mori T, Hoshino N, Meada H. Timing and technical problem in BCG vaccination during childhood. Koshu Eisei Joho 1993;No.1:29-32. (in Japanese)
23. Mori T. TB control policy by BCG vaccination in future. Jpn J Public Health 2002;49:717-9. (in Japanese)
24. Global tuberculosis programme and global programme on vaccines. Statement on BCG revaccination for the prevention of tuberculosis. Wkly Epidemiol Rec 1995;70:229-231.
25. Mori T, Yamauchi Y, Shiozawa K. Lymph node swelling due to bacille Calmette-Guerin vaccination with multipuncture method. Tuber Lung Dis 1996;77:269-73.
26. Nakanishi M, Tame A, Furuta H, Kobayashi I, Kawamura N, Ariga T, et al. Enzyme replacement therapy for a patient with adenosine deaminase deficiency using polyethylene glycol-modified adenosine deaminase. Nippon Shonika Gakkai Zasshi 1994;98:1738-46. (in Japanese)
27. Tsuge I, Horibe K, Nakajima K, Yamamoto M, Numata S, Abe T, et al. A case of severe combined immunodeficiency accompanied with miliary BCG infectious disease. Shoni Kansen Meneki 1993;5:91. (in Japanese, abstract)
28. Takamatsu O, Sekimoto M, Hyashi K, Yamamoto H, Irie N, Mori K, et al. A summary on BCG adverse reaction monitoring system in Japan. 2001. Ministry of Health and Welfare, Tokyo, Japan, (in Japanese)
29. Report of health status survey after vaccination. TB and Infectious Disease Surveillance Division. Ministry of Health and Welfare, Tokyo, Japan, 1999. (in Japanese)
30. Aihara R, Shimakawa K, Yuasa Y, Tanaka H. A nine-month-old boy with multiple lymphadenitis and general tuberculide following BCG vaccination. Nippon Shonika Gakkai Zasshi 1993;97:1490-1495. (in Japanese)
31. Akashi T, Ishi M, Yamanaka K, Mori M, Ichiyama S, Mori T. A case of disseminated BCG infection determined by genetic diagnosis. Jpn J Public Health 2000;64:65-69. (in Japanese)
32. Rahman M, Sekimoto M, Fukui T. An economic evaluation of universal BCG vaccination of infants in Japan. Kekkaku 2000;75:298. (abstract)
33. Rahman M, Takahashi O, Takamatsu I, Sekimoto M, Hira K, Fukui T. Cost analysis of pediatric tuberculosis treatment in Japan. Int J Tubercle Lung Dis (in press).
34. Rahman M, Sekimoto M, and Fukui T. Economic evaluation of BCG revaccination among the school children in Japan. J Gen Intern Med 2000;15(Suppl 1):92. (abstract)
35. Rahman M, Sekimoto M, Hira K, Koyama H, Imanaka Y, Fukui T. Is Bacillus Calmette-Guerin revaccination necessary for Japanese children? Prev Med 2002;35:70-7.
36. Romanus V, Svensson A, Hallander HO. The impact of changing BCG coverage on tuberculosis incidence in Swedish-born children between 1969 and 1989. Tuber Lung Dis 1992;73:150-61.
37. Trnka L, Dankova D, Svandova E. Six years' experience with the discontinuation of BCG vaccination. 2. Cost and benefit of mass BCG vaccination. Tuber Lung Dis 1993;74:288-92.
38. Coker R. Lessons from New York's tuberculosis epidemic. Tuberculosis is a political as much as a medical problem - and so are the solutions. BMJ 1998;317:616.
39. Sheldon T. Increase in tuberculosis causes concern to Dutch. BMJ 1995;311:587-8.
40. Global Tuberculosis Control. Who Report 2001. World Health Organization. Geneva, Switzerland.
41. Ohmori M. The factors related to the stagnation in the decline of tuberculosis incidence in Japan. Kekkaku 1993;68:581-8. (in Japanese)
42. Ahiko T. The examination of tuberculosis contacts: the current situations and perspective in Japan. Kekkaku 1995;70:67-72. (in Japanese)
43. Aoki M. Recent situation of tuberculosis group infection in Japan. Tuberculosis Prevention and Control Committee. 1999. Ministry of Health and Welfare. Tokyo, Japan, (in Japanese)
44. Mori T. Where do we stand with BCG vaccination programme in Japan? Kekkaku 2001;76:385-97. (in Japanese)
45. Booth H, Pollitt C, Jessen EC, Hendrick DJ, Cant AJ. When is referral of Heaf test positive schoolchildren worthwhile? Prospective study. BMJ 1996;313:726-7.
46. Takamatsu I, Kameda M, Inoue T, Toyoshima K. The current situations and measures in the future in the childhood tuberculosis. Kekkaku 1995;70:57-65. (in Japanese)